Edition:
United Kingdom

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

713.30GBp
14 Dec 2018
Change (% chg)

-3.70 (-0.52%)
Prev Close
717.00
Open
710.00
Day's High
720.10
Day's Low
702.30
Volume
98,187
Avg. Vol
106,401
52-wk High
1,064.38
52-wk Low
438.50

Chart for

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: -0.01
Market Cap(Mil.): £282.36
Shares Outstanding(Mil.): 3,106.25
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.00 -- --
ROI: -24.52 9.01 14.96
ROE: -105.55 10.15 16.52

BRIEF-Oxford BioMedica Notes Longer-Term Analyses From Pivotal Kymriah Trials

* NOTES AN ANNOUNCEMENT BY NOVARTIS ON LONGER-TERM ANALYSES OF BOTH ELIANA AND JULIET PIVOTAL TRIALS

03 Dec 2018

Earnings vs. Estimates